IGMS — IGM Biosciences Share News
0.000.00%
Last trade - 00:00- $76.57m
- -$27.73m
- $2.68m
U.S. RESEARCH ROUNDUP- Amerant Bancorp, BlackRock, Equinix
IGM Bio falls after plans to cut spending on cancer drug candidates
Brief: IGM Biosciences Announces Strategic Pivot To Focus Exclusively On Autoimmunity
U.S. RESEARCH ROUNDUP-Allstate, Bluebird Bio, Vicinity Motor
Brief: IGM Biosciences Q2 Net Income USD -47.902 Million
IGM Biosciences Inc expected to post a loss of 4 cents a share - Earnings Preview
IGM Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: IGM Biosciences Q1 Net Income USD -49.816 Million
IGM Biosciences Inc expected to post a loss of 83 cents a share - Earnings Preview
Brief: IGM Biosciences Announces Refocusing of Sanofi Collaboration
Brief: IGM Biosciences Announces Fourth Quarter And Full Year 2023 Financial Results
Brief: IGM Biosciences Q4 Net Income USD -60.695 Million
Brief: Igm Biosciences Inc Strategic Refocusing Activities Expected To Be Substantially Complete By June 30 2024
U.S. RESEARCH ROUNDUP- Boeing, McDonald's, Quaker Houghton
U.S. RESEARCH ROUNDUP- Autozone Inc, Digital Realty Trust Inc, Equinix Inc
Brief: IGM Biosciences Files For Mixed Shelf Of Up To $400 Mln - SEC Filing
Brief: IGM Biosciences Q3 Net Income USD -61.989 Million
IGM Biosciences Inc expected to post a loss of $1.22 a share - Earnings Preview
Brief: Igm Biosciences Announces Retirement Of Chairman Michael Loberg, Ph.D. From Board Of Directors And Appointment Of Elizabeth H.Z. Thompson, Ph.D. To Board Of Directors